The biggest phase 3 clinical trial showed a 28.7% reduction in weight in participants with obesity or overweight
This comprehensive approach produces significantly better, safer, and more sustainable outcomes
Similarly, the SCALE (Satiety and Clinical AdiposityLiraglutide Evidence) trials published in The Lancet (2015) demonstrated that liraglutide 3.0 mg daily resulted in approximately 8% weight loss over 56 weeks
A direct comparison of tirzepatide (Zepbound) and semaglutide (Wegovy) showed that people on tirzepatide lost an average of 20% of their body weight while those on semaglutide lost about 14% in just over a year (SURMOUNT-5 trial)
Drinks to avoid include dairy milk (especially if it irritates your gut), carbonated beverages, alcohol , and anything with lots of added sugar
While the exact time may vary, the weekly schedule should remain as stable as possible to achieve optimal results [14]